Science Official · Open calls
Open calls for research funding
Grants, fellowships and prizes you can still apply for, in one list, by deadline. 1,703 open calls from 202 funders today. You always apply on the funder’s own page; we link to it.
3days leftLongitudinal population studies strategic prioritisation exerciseMedical Research Council · UK Research and InnovationDeadline 17 Nov 20265days leftGroundWork Open CallGroundWork · Horizon Europe cascade funding · Regenerative living labs to improve soil ecosystem funct…Deadline 19 Nov 20269days leftSYSTEMEU - Financial Support to Third Parties (FSTP)
What is the aim?
To support digital innovations in healthcare, energy and mobility as they progress from the prototype stage (TRL 6) to a market-ready system (TRL 8).
Who can take part?
Regions: Bavaria (DE), Norte Region (PT), Castile and León (ES), Romania (RO) and Tuzla (BiH) only.
Consortia: 2–8 partners from at least 2–5 regions (depending on project size).
Type: Triple Helix (academia, business, public authorities).
Project sizes & budget
Flagship: up to €2.2 million (5–8 partners, all regions). Proposed by consortia composed by 5SYSTEMEUDeadline 23 Nov 202610days leftMSCA Doctoral Networks 2026European Commission · Horizon Europe · Marie Skłodowska-Curie ActionsDeadline 24 Nov 202617days leftWomen Leadership CategoryEuropean Commission · Horizon EuropeDeadline 1 Dec 202617days leftUnderstanding inhabitant’s experiences of neighbourhoods to support their health and well-beingEuropean Commission · Horizon EuropeDeadline 1 Dec 202617days leftInnovative approaches for the spatial design of neighbourhoodsEuropean Commission · Horizon EuropeDeadline 1 Dec 202619days leftUK Obesity Research Institute: full applicationMedical Research Council · UK Research and InnovationDeadline 3 Dec 202626days leftUNITE Open Call 2 for Joint Interregional ProjectsUNITEDeadline 10 Dec 202626days leftPublic Engagement Spark Awards 2026BScience and Technology Facilities Council · UK Research and InnovationDeadline 10 Dec 202630days leftComputational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)National Institutes of Health · Human Genome ResearchDeadline 14 Dec 202630days leftSystematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)National Institutes of Health · Human Genome ResearchDeadline 14 Dec 202630days leftGenomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)National Institutes of Health · Human Genome ResearchDeadline 14 Dec 202659days leftERC Consolidator GrantEuropean Research Council · Horizon Europe · ERCDeadline 12 Jan 202760days leftInnovation Validation Call 2027EIT Health 26-28 · Horizon Europe cascade funding · EIT Health Business Plan 2026-2028Deadline 13 Jan 202761days leftMulti-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations (IICS4all 2027)ERA4Health · Horizon Europe cascade funding · Fostering a European Research Area for Health ResearchDeadline 14 Jan 202767days leftCell and Gene Therapy for Personalised Medicine (CGT4PM2027)EP PerMed · Horizon Europe cascade funding · European Partnership for Personalised MedicineDeadline 20 Jan 202780days leftUnlocking the potential of academic intellectual assets for industry, SMEs and startups (CSA)European Commission · Horizon EuropeDeadline 2 Feb 202781days leftMRC Centre of Research Excellence: round five: outline applicationMedical Research Council · UK Research and InnovationDeadline 3 Feb 202786days leftNeural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)National Institutes of Health · Drug Use and Addiction Research ProgramsDeadline 8 Feb 202787days leftCarcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)National Institutes of Health · Cancer Cause and Prevention ResearchDeadline 9 Feb 202789days leftAccelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)National Institutes of Health · Allergy and Infectious Diseases ResearchDeadline 11 Feb 202795days leftPrevention and management of chronic non-communicable diseases in children and young people (GACD)European Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of innovative antimicrobials against pathogens resistant to antimicrobialsEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftTools and technologies to support health adaptation to climate changeEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of cell-free protein synthesis platforms for discovery and/or production of biologicalsEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftIntegrating climate-related exposures into the human exposome and characterising its changes in response to climate changeEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftClinical trials for advancing innovative interventions for neurodegenerative diseasesEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftAddressing disabilities through the life course to support independent living and inclusionEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftPersonalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of novel small molecule antiviral therapeutics for pathogens with epidemic potentialEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftDevelopment of monoclonal antibodies to prevent and treat infections from FlavivirusesEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftInnovative healthcare interventions for non-communicable diseasesEuropean Commission · Horizon EuropeDeadline 17 Feb 202795days leftPortable and versatile Point-of-care diagnosticsEuropean Commission · Horizon EuropeDeadline 17 Feb 2027Opens25 Nov 2026HORIZON-EIC-2027-PATHFINDEROPEN-two-stageEuropean Innovation Council · Horizon Europe · EICDeadline 25 Feb 2027107days leftAccelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)National Institutes of Health · 21st Century Cures Act - Precision Medicine Initiative Deadline 1 Mar 2027Opens17 Dec 2026European Partnership on Innovative SMEs/Eurostars: joint transnational call for proposals (CALL 12 of Eurostars-3)InnovativeSMEs · Horizon Europe cascade funding · European Partnership on Innovative SMEsDeadline 4 Mar 2027111days leftDiscovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)National Institutes of Health · Mental Health Research GrantsDeadline 5 Mar 2027